Microbix Biosystems Inc. Reports 11% Growth in Product Volume for Nine Months
TORONTO, Aug. 12 /CNW/ - Microbix Biosystems Inc. (MBX:TSX), a biotechnology company focused on virology and biological technologies, reported sales volume grew by 11% for the first nine months of fiscal 2010, compared to the same period in 2009. Double digit sales growth was, however, offset by the impact on revenue of strongly negative currency exchange rates.